Yingjun Li
Affiliations: | Johns Hopkins University School of Medicine, Baltimore, MD, United States |
Google:
"Yingjun Li"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Pan F, Zhou Q, Yan M, et al. (2024) Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CL) inhibitors with anti-coronavirus activities. Bioorganic Chemistry. 154: 107988 |
Chen Q, Zhou Q, Yang S, et al. (2024) Identification of adenosine analogues as nsp14 N7‑methyltransferase inhibitors for treating coronaviruses infection. Bioorganic Chemistry. 153: 107894 |
Chen Y, Zhou Q, Pan F, et al. (2024) Synthesis and anti-influenza virus activity of substituted dibenzoxepine-based baloxavir derivatives. European Journal of Medicinal Chemistry. 280: 116922 |
Zhou Q, Luo Y, Zhu Y, et al. (2023) Nonsteroidal anti-inflammatory drugs (NSAIDs) and nucleotide analog GS-441524 conjugates with potent in vivo efficacy against coronaviruses. European Journal of Medicinal Chemistry. 249: 115113 |
Cheng H, Fu L, Yang X, et al. (2023) Screening and identification of 3-aryl-quinolin-2-one derivatives as antiviral agents against influenza A. Journal of Medical Virology. 95: e28327 |
Yang Y, Yu Q, Hu L, et al. (2022) Enantioselective semisynthesis of novel cephalotaxine esters with potent antineoplastic activities against leukemia. European Journal of Medicinal Chemistry. 244: 114731 |
Li Y, Huang Y, Cheng H, et al. (2022) Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells. Frontiers in Chemistry. 10: 910353 |
Li Y, Pasunooti KK, Peng H, et al. (2020) Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors. Acs Medicinal Chemistry Letters. 11: 1111-1117 |
Yang W, Li Y, Ai Y, et al. (2019) Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation. Journal of Medicinal Chemistry |
Liu JO, Guo Z, Cheng Z, et al. (2019) Discovery of a potent GLUT inhibitor using rapafucin 3D microarrays. Angewandte Chemie (International Ed. in English) |